Robert Benjamin Stein
Officer at Mimedx Group, Inc. (MDXG)
Robert Benjamin Stein has filed 18 insider reports with the SEC since March 2021, as director at PolyPid Ltd. (PYPD), director at Protagenic Therapeutics, Inc.\new (PTIX) and officer at Mimedx Group, Inc. (MDXG). Robert Benjamin Stein made no open-market purchases or sales in the last 12 months. The latest filing, on July 17, 2026, reports grant or award at PolyPid Ltd. (PYPD).
- Filings
- 18
- Companies
- 3
- Bought on market
- None
- Sold on market
- $907K
Companies where Robert Benjamin Stein is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Directorsince March 2026 | $6.12 | Jul 17, 2026 | |||||
| Director | $0.74 | Mar 30, 2024 | |||||
| Officer | 317,803 | $907K | $3.05 | May 17, 2023 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jul 15, 2026PYPDSEC Form 4 filed by Director Stein Robert BenjaminForm 4Grant or award
- Mar 18, 2026PYPDRobert Benjamin Stein became an insiderForm 3New insider
- Mar 25, 2024PTIXSEC Form 4 filed by Stein Robert BenjaminForm 4Grant or award
- May 16, 2023-$83.8KMDXGSEC Form 4 filed by Stein Robert BenjaminForm 4Open-market sale
- May 10, 2023-$34.8KMDXGSEC Form 4 filed by Stein Robert BenjaminForm 4Open-market sale
- May 4, 2023-$276KMDXGSEC Form 4 filed by Stein Robert BenjaminForm 4Open-market sale
- Apr 25, 2023-$22.4KMDXGSEC Form 4 filed by Stein Robert BenjaminForm 4Open-market sale
- Apr 11, 2023-$19.8KMDXGSEC Form 4 filed by Stein Robert BenjaminForm 4Open-market sale
- Mar 13, 2023MDXGSEC Form 4: Stein Robert Benjamin was granted 135,065 shares, increasing direct ownership by 51% to 401,383 unitsForm 4Grant or award
- Mar 7, 2023-$52.4KMDXGSEC Form 4: Stein Robert Benjamin sold $52,442 worth of shares (12,355 units at $4.24), decreasing direct ownership by 4% to 266,318 units to satisfy withholding taxForm 4Open-market sale
- Sep 13, 2022-$94.1KMDXGSEC Form 4: Stein Robert Benjamin sold $94,069 worth of shares (27,329 units at $3.44), decreasing direct ownership by 9% to 278,673 unitsForm 4Open-market sale
- Aug 12, 2022-$34.3KMDXGSEC Form 4: Stein Robert Benjamin sold $34,344 worth of shares (8,503 units at $4.04), decreasing direct ownership by 3% to 306,002 units (withholding obligation)Form 4Open-market sale
- Aug 4, 2022-$70.6KMDXGSEC Form 4: Stein Robert Benjamin sold $70,590 worth of shares (19,500 units at $3.62), decreasing direct ownership by 6% to 314,505 unitsForm 4Open-market sale
- Jun 28, 2022-$50.7KMDXGSEC Form 4: Stein Robert Benjamin sold $50,662 worth of shares (14,600 units at $3.47), decreasing direct ownership by 4% to 334,005 unitsForm 4Open-market sale
- Apr 8, 2022MDXGSEC Form 4: Stein Robert Benjamin was granted 178,571 shares, increasing direct ownership by 105% to 348,605 unitsForm 4Grant or award
- Mar 8, 2022-$56.7KMDXGSEC Form 4: Stein Robert Benjamin sold $56,714 worth of shares (11,672 units at $4.86), decreasing direct ownership by 6% to 170,034 units (tax withholding)Form 4Open-market sale
- Aug 16, 2021-$111KMDXGSEC Form 4: Stein Robert Benjamin sold $110,968 worth of Common Stock (9,362 units at $11.85), decreasing direct ownership by 5% to 181,706 unitsForm 4Open-market sale
- Mar 4, 2021MDXGSEC Form 4: Benjamin Robert Stein was granted 109,235 units of Common Stock, increasing direct ownership by 133% to 191,068 unitsForm 4Grant or award
Also sits on boards with
Officers and directors who share two or more companies with Robert Benjamin Stein.
Compare Robert Benjamin Stein with
- Robert Benjamin Stein vs Timothy R Wright2 shared
- Robert Benjamin Stein vs Garo H Armen1 shared
- Robert Benjamin Stein vs Ori Warshavsky1 shared
- Robert Benjamin Stein vs Jonathan Missulawin1 shared
- Robert Benjamin Stein vs Dalit Fellous Hazan1 shared
- Robert Benjamin Stein vs Yechezkel Barenholz1 shared
Other insiders at the same companies
- Garo H ArmenPTIX
- Ori WarshavskyPYPD
- Dalit Fellous HazanPYPD
- Jonathan MissulawinPYPD
- Yechezkel BarenholzPYPD
- Nir Dror-DarwishPYPD
- Joseph BenAmramPYPD
- Itzhak KrinskyPYPD
- Brooke StoryPYPD
- Dikla Czaczkes AkselbradPYPD
- Rice DougMDXG
- Kimberly Maersk-MollerMDXG
- James L BiermanMDXG
- Dorothy E PuhyMDXG
- Todd NewtonMDXG
- William A HawkinsMDXG
Questions about Robert Benjamin Stein
- What is Robert Benjamin Stein's role at Mimedx Group, Inc.?
- Robert Benjamin Stein reports to the SEC as officer at Mimedx Group, Inc. (MDXG), according to the latest filing on May 17, 2023. Robert Benjamin Stein has also filed as director at PolyPid Ltd. (PYPD) and director at Protagenic Therapeutics, Inc.\new (PTIX).
- How many shares does Robert Benjamin Stein own?
- After the latest filing that states it, Robert Benjamin Stein directly owned 317,803 shares of Mimedx Group, Inc. (MDXG). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Robert Benjamin Stein bought or sold stock recently?
- The most recent open-market sale was on May 16, 2023: sold 13,972 shares of Mimedx Group, Inc. (MDXG) for $83.8K at an average of $6.00.
- How do I get alerts when Robert Benjamin Stein files?
- Follow Robert Benjamin Stein on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Robert Benjamin Stein (SEC CIK 0001597158). Totals count each trade once, skipping amendments whose original is on file, from Mar 8, 2021 on. View on SEC EDGAR · Get this as JSON